Clinical Manifestations of Hypoparathyroidism

The Parathyroids: Basic and Clinical Concepts: Third Edition

Volumn , Issue , 2015, Pages 761-770

  Mannstadt, Michael ^a   Mitchell, Deborah M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cataracts; Hypocalcemia; Hypocalcemic cardiomyopathy; Myopathy; Paresthesia; Seizures; Tetany

Indexed keywords

EID: 84942776547     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397166-1.00053-9     Document Type: Chapter

References (128)

1. Steinberg H., Waldron B.R. Idiopathic hypoparathyroidism; an analysis of fifty-two cases, including the report of a new case. Medicine (Baltimore) 1952, 31:133-154.
2. Powers J., Joy K., Ruscio A., Lagast H. Prevalence and incidence of hypoparathyroidism in the USA using a large claims database. J Bone Miner Res 2013, 28:2570-2576.
3. Parathyroid Insufficiency. Lancet 1961, 278:1441-1442.
4. Frankenhaeuser B., Hodgkin A.L. The action of calcium on the electrical properties of squid axons. J Physiol 1957, 137:218-244.
5. Bilezikian J.P., Khan A., Potts J.T., Brandi M.L., Clarke B.L., Shoback D., et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 2011, 26:2317-2337.
6. Layzer R.B., Rowland L.P. Cramps. N Engl J Med 1971, 285:31-40.
7. Williams G.T., Brown M. Laryngospasm in hypoparathyroidism. J Laryngol Otol 1974, 88:369-373.
8. van Veelen M.J., Visser M.F., Baggen M.G., Dees A. Hypocalcaemic laryngospasm in the emergency department. BMJ Case Rep 2011, 2011.
9. Chakrabarty A.D. Adult primary hypoparathyroidism: a rare presentation. Indian J Endocrinol Metab 2013, 17:S201-S202.
10. Urbano F.L. Signs of hypocalcemia: Chvostek's and Trousseau's signs. Hospital Physician 2000;March, 43-45.
11. Hoffman E. The Chvostek sign; a clinical study. Am J Surg 1958, 96:33-37.
12. Fonseca O.A., Calverley J.R. Neurological manifestations of hypoparathyroidism. Arch Intern Med 1967, 120:202-206.
13. Schaaf M., Payne C.A. Effect of diphenylhydantoin and phenobarbital on overt and latent tetany. N Engl J Med 1966, 274:1228-1233.
14. Kugelberg E. Activation of human nerves by ischemia; Trousseau's phenomenon in tetany. Arch Neurol Psychiatry 1948, 60:140-164.
15. Mrowka M., Knake S., Klinge H., Odin P., Rosenow F. Hypocalcemic generalised seizures as a manifestation of iatrogenic hypoparathyroidism months to years after thyroid surgery. Epileptic Disord 2004, 6:85-87.
16. Bronsky D., Kushner D.S., Dubin A., Snapper I. Idiopathic hypoparathyroidism and pseudohypoparathyroidism: case reports and review of the literature. Medicine (Baltimore) 1958, 37:317-352.
17. Mitchell D.M., Regan S., Cooley M.R., Lauter K.B., Vrla M.C., Becker C.B., et al. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 2012, 97:4507-4514.
18. Underbjerg L., Sikjaer T., Mosekilde L., Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 2013, 28:2277-2285.
19. Eraut D. Idiopathic hypoparathyroidism presenting as dementia. Br Med J 1974, 1:429-430.
20. Klawans H.L., Lupton M., Simon L. Calcification of the basal ganglia as a cause of levodopa-resistant parkinsonism. Neurology 1976, 26:221-225.
21. Berendes K., Dorstelmann D. Unsuccessful treatment with levodopa of a Parkinsonian patient with calcification of the basal ganglia. J Neurol 1978, 218:51-54.
22. Berger J.R., Ross D.B. Reversible Parkinson syndrome complicating postoperative hypoparathyroidism. Neurology 1981, 31:881-882.
23. Abe S., Tojo K., Ichida K., Shigematsu T., Hasegawa T., Morita M., et al. A rare case of idiopathic hypoparathyroidism with varied neurological manifestations. Intern Med 1996, 35:129-134.
24. Hossain M. Neurological and psychiatric manifestations in idiopathic hypoparathyroidism: response to treatment. J Neurol Neurosurg Psychiatry 1970, 33:153-156.
25. Tabaee-Zadeh M.J., Frame B., Kapphahn K. Kinesiogenic choreoathetosis and idiopathic hypoparathyroidism. N Engl J Med 1972, 286:762-763.
26. Salti I., Faris A., Tannir N., Khouri K. Rapid correction by 1-alpha-hydroxycholecalciferol of hemichorea in surgical hypoparathyroidism. J Neurol Neurosurg Psychiatry 1982, 45:89-90.
27. Hattori H., Yorifuji T. Infantile convulsions and paroxysmal kinesigenic choreoathetosis in a patient with idiopathic hypoparathyroidism. Brain Dev 2000, 22(7):449-450.
28. Kowdley K.V., Coull B.M., Orwoll E.S. Cognitive impairment and intracranial calcification in chronic hypoparathyroidism. Am J Med Sci 1999, 317:273-277.
29. Goswami R., Sharma R., Sreenivas V., Gupta N., Ganapathy A., Das S. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 2012, 77:200-206.
30. Manyam B.V. What is and what is not "Fahr's disease.". Parkinsonism Relat Disord 2005, 11:73-80.
31. Wang C., Li Y., Shi L., Ren J., Patti M., Wang T., et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 2012, 44:254-256.
32. Aggarwal S., Kailash S., Sagar R., Tripathi M., Sreenivas V., Sharma R., et al. Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. Eur J Endocrinol 2013, 168:895-903.
33. Hadker N., Egan J., Sanders J., Lagast H., Clarke B.L. Clinical symptoms and morbidities reported among patients with hypoparathyroidism: Patients' Attitudes and Responses About hypoparathyroiDism tOleration eXplored (PARADOX Study) 2013, Presented at Endocrine Society Annual Meeting 2013, San Francisco, USA, Abstract SUN-249.
34. Kumar G., Kaur D., Aggarwal P., Khurana T. Hypoparathyroidism presenting as cognitive dysfunction. BMJ Case Rep 2013, 2013.
35. Arlt W., Fremerey C., Callies F., Reincke M., Schneider P., Timmermann W., et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 2002, 146:215-222.
36. Bago A.G., Dimitrov E., Saunders R., Seress L., Palkovits M., Usdin T.B., et al. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 2009, 162:128-147.
37. Usdin T.B., Wang T., Hoare S.R., Mezey E., Palkovits M. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues. Front Neuroendocrinol 2000, 21:349-383.
38. Usdin T.B., Gruber C., Bonner T.I. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 1995, 270:15455-15458.
39. Cusano N.E., Rubin M.R., McMahon D.J., Irani D., Tulley A., Sliney J., et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab 2013, 98:2356-2361.
40. Braunwald E., Bonow R.O. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 2012, Saunders, Philadelphia. 9th ed.
41. Vered I., Vered Z., Perez J.E., Jaffe A.S., Whyte M.P. Normal left ventricular performance documented by Doppler echocardiography in patients with long-standing hypocalcemia. Am J Med 1989, 86:413-416.
42. Rose E. Hypoparathyroidism. Clinics 1943, 1179-1196.
43. Schulman J.L., Ratner H. Idiopathic hypoparathyroidism with bony demineralization and cardiac decompensation. Pediatrics 1955, 16:848-856.
44. Bashour T., Basha H.S., Cheng T.O. Hypocalcemic cardiomyopathy. Chest 1980, 78:663-665.
45. Giles T.D., Iteld B.J., Rives K.L. The cardiomyopathy of hypoparathyroidism. Another reversible form of heart muscle disease. Chest 1981, 79:225-229.
46. Connor T.B., Rosen B.L., Blaustein M.P., Applefeld M.M., Doyle L.A. Hypocalcemia precipitating congestive heart failure. N Engl J Med 1982, 307:869-872.
47. Newman D.B., Fidahussein S.S., Kashiwagi D.T., Kennel K.A., Kashani K.B., Wang Z., et al. Reversible cardiac dysfunction associated with hypocalcemia: a systematic review and meta-analysis of individual patient data. Heart Fail Rev 2014, 19:199-205.
48. Tziomalos K., Kakavas N., Kountana E., Harsoulis F., Basayannis E. Reversible dilated hypocalcaemic cardiomyopathy in a patient with primary hypoparathyroidism. Clin Endocrinol (Oxf) 2006, 64:717-718.
49. Ballane G.T., Sfeir J.G., Dakik H.A., Brown E.M., El-Hajj Fuleihan G. Use of recombinant human parathyroid hormone in hypocalcemic cardiomyopathy. Eur J Endocrinol 2012, 166:1113-1120.
50. Huddle K.R. Cardiac dysfunction in primary hypoparathyroidism. A report of 3 cases. S Afr Med J 1988, 73:242-244.
51. Drop L.J., Geffin G.A., O'Keefe D.D., Newell J.B., Jacobs M.L., Fowler B.N., et al. Relation between ionized calcium concentration and ventricular pump performance in the dog under hemodynamically controlled conditions. Am J Cardiol 1981, 47:1041-1051.
52. Lang R.M., Fellner S.K., Neumann A., Bushinsky D.A., Borow K.M. Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med 1988, 108:524-529.
53. Bers D.M. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000, 87:275-281.
54. Blake J. Eye signs in idiopathic hypoparathyroidism. Trans Ophthalmol Soc UK 1976, 96:448-451.
55. Rajendram R., Deane J.A., Barnes M., Swift P.G., Adamson K., Pearce S., et al. Rapid onset childhood cataracts leading to the diagnosis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Am J Ophthalmol 2003, 136:951-952.
56. Pohjola S. Ocular manifestations of idiopathic hypoparathyroidism. Acta Ophthalmol (Copenh) 1962, 40:255-265.
57. Ireland A.W., Hornbrook J.W., Neale F.C., Posen S. The crystalline lens in chronic surgical hypoparathyroidism. Arch Intern Med 1968, 122:408-411.
58. Walsh F.B., Murray R.G. Ocular manifestations of disturbances in calcium metabolism. Am J Ophthalmol 1953, 36:1657-1676.
59. Kahn H.A., Leibowitz H.M., Ganley J.P., Kini M.M., Colton T., Nickerson R.S., et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977, 106:17-32.
60. Hough T.A., Bogani D., Cheeseman M.T., Favor J., Nesbit M.A., Thakker R.V., et al. Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Proc Natl Acad Sci USA 2004, 101:13566-13571.
61. Sanderson J., Marcantonio J.M., Duncan G. A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification. Invest Ophthalmol Vis Sci 2000, 41:2255-2261.
62. Rhodes J.D., Sanderson J. The mechanisms of calcium homeostasis and signalling in the lens. Exp Eye Res 2009, 88:226-234.
63. Bunce G.E., Kinoshita J., Horwitz J. Nutritional factors in cataract. Annu Rev Nutr 1990, 10:233-254.
64. Ayuk J., Matthews T., Tayebjee M., Gittoes N.J. A blind panic. Lancet 2001, 357:1262.
65. Grant D.K. Papilloedema and fits in hypoparathyroidism, with a report of three cases. Q J Med 1953, 22:243-259.
66. Bajandas F.J., Smith J.L. Optic neuritis in hypoparathyroidism. Neurology 1976, 26:451-454.
67. Palmer R.F., Searles H.H., Boldrey E.B. Papilloedema and hypoparathyroidism simulating brain tumor. J Neurosurg 1959, 16:378-384.
68. Fowler W.M., Ling S. Convulsions and papilledema in a child with idiopathic hypoparathyroidism. Calif Med 1961, 95:180-182.
69. Sambrook M.A., Hill L.F. Cerebrospinal fluid absorption in primary hypoparathyroidism. J Neurol Neurosurg Psychiatry 1977, 40:1015-1017.
70. Sheldon R.S., Becker W.J., Hanley D.A., Culver R.L. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association. Can J Neurol Sci 1987, 14:622-625.
71. Gass J.D. The syndrome of keratoconjunctivitis, superficial moniliasis, idiopathic hypoparathyroidism and Addison's disease. Am J Ophthalmol 1962, 54:660-674.
72. Simpson J.A. Dermatological changes in hypocalcaemia. Br J Dermatol 1954, 66:1-15.
73. Sarkar S., Mondal M., Das K., Shrimal A. Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study. Indian J Endocrinol Metab 2012, 16:819-820.
74. Learner N., Brown C.L. Ectodermal Disorders in Chronic Hypoparathyroidism. J Clin Endocrinol Metab 1943, 3:261-264.
75. Tercedor J., Rodenas J.M., Munoz M., Cespedes S., Naranjo R. Generalized pustular psoriasis and idiopathic hypoparathyroidism. Arch Dermatol 1991, 127:1418-1419.
76. Kawamura A., Kinoshita M.T., Suzuki H. Generalized pustular psoriasis with hypoparathyroidism. Eur J Dermatol 1999, 9:574-576.
77. Lee Y., Nam Y.H., Lee J.H., Park J.K., Seo Y.J. Hypocalcaemia-induced pustular psoriasis-like skin eruption. Br J Dermatol 2005, 152:591-593.
78. Dent C.E., Garretts M. Skin changes in hypocalcaemia. Lancet 1960, 1:142-146.
79. Harell-Steinberg A., Ziprkowski L., Haim S., Gafni J., Levin M. Observations on hypoparathyroidism. I. Exfoliative dermatitis as the presenting sign of hypoparathyroidism: a case report. J Clin Endocrinol Metab 1957, 17:1094-1098.
80. Hirano K., Ishibashi A., Yoshino Y. Cutaneous manifestations in idiopathic hypoparathyroidism. Arch Dermatol 1974, 109:242-244.
81. Kalb R.E., Grossman M.E. Ectodermal defects and chronic mucocutaneous candidiasis in idiopathic hypoparathyroidism. J Am Acad Dermatol 1986, 15:353-356.
82. Pisanty S., Garfunkel A. Familial hypoparathyroidism with candidiasis and mental retardation. Oral Surg Oral Med Oral Pathol 1977, 44:374-383.
83. Jensen S.B., Illum F., Dupont E. Nature and frequency of dental changes in idiopathic hypoparathyroidism and pseudohypoparathyroidism. Scand J Dent Res 1981, 89:26-37.
84. Nikiforuk G., Fraser D. The etiology of enamel hypoplasia: a unifying concept. J Pediatr 1981, 98:888-893.
85. Wolf S.M. CPK activity in hypoparathyroidism. N Engl J Med 1973, 288:215.
86. Hower J., Struck H., Tackmann W., Stolecke H. CPK activity in hypoparathyroidism. N Engl J Med 1972, 287:1098.
87. Walters R.O. Idiopathic hypoparathyroidism with extrapyramidal and myopathic features. Arch Dis Child 1979, 54:236-238.
88. Kruse K., Scheunemann W., Baier W., Schaub J. Hypocalcemic myopathy in idiopathic hypoparathyroidism. Eur J Pediatr 1982, 138:280-282.
89. Yamaguchi H., Okamoto K., Shooji M., Morimatsu M., Hirai S. Muscle histology of hypocalcaemic myopathy in hypoparathyroidism. J Neurol Neurosurg Psychiatry 1987, 50:817-818.
90. Van Offel J.F., De Gendt C.M., De Clerck L.S., Stevens W.J. High bone mass and hypocalcaemic myopathy in a patient with idiopathic hypoparathyroidism. Clin Rheumatol 2000, 19:64-66.
91. Barber J., Butler R.C., Davie M.W., Sewry C.A. Hypoparathyroidism presenting as myopathy with raised creatine kinase. Rheumatology (Oxford) 2001, 40:1417-1418.
92. Nora D.B., Fricke D., Becker J., Gomes I. Hypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism: case report. Arq Neuropsiquiatr 2004, 62:154-157.
93. Syriou V., Kolitsa A., Pantazi L., Pikazis D. Hypoparathyroidism in a patient presenting with severe myopathy and skin rash. Case report and review of the literature. Hormones (Athens) 2005, 4:161-164.
94. Zambelis T., Licomanos D., Leonardos A., Potagas C. Neuromyotonia in idiopathic hypoparathyroidism. Neurol Sci 2009, 30:495-497.
95. Kajitani T.R., Silva R.V., Bonfa E., Pereira R.M. Hypoparathyroidism mimicking ankylosing spondylitis and myopathy: a case report. Clinics (Sao Paulo) 2011, 66:1287-1290.
96. Policepatil S.M., Caplan R.H., Dolan M. Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 2012, 111:173-175.
97. Snowdon J.A., Macfie A.C., Pearce J.B. Hypocalcaemic myopathy with paranoid psychosis. J Neurol Neurosurg Psychiatry 1976, 39:48-52.
98. Shane E., McClane K.A., Olarte M.R., Bilezikian J.P. Hypoparathyroidism and elevated muscle enzymes. Neurology 1980, 30:192-195.
99. Ishikawa T., Inagaki H., Kanayama M., Manzai T. Hypocalcemic hyper-CK-emia in hypoparathyroidism. Brain Dev 1990, 12:249-252.
100. Roca B., Minguez C., Saez-Royuela A., Simon E. Dementia, myopathy, and idiopathic hypoparathyroidism. Postgrad Med J 1995, 71:702.
101. Heubi J.E., Partin J.C., Schubert W.K. Hypocalcemia and steatorrhea-clues to etiology. Dig Dis Sci 1983, 28:124-128.
102. Abboud B., Daher R., Boujaoude J. Digestive manifestations of parathyroid disorders. World J Gastroenterol 2011, 17:4063-4066.
103. Morse W.I., Cochrane W.A., Landrigan P.L. Familial hypoparathyroidism with pernicious anemia, steatorrhea and adrenocortical insufficiency: a variant of mucoviscidosis. N Engl J Med 1961, 264:1021-1026.
104. Lorenz R., Burr I.M. Idiopathic hypoparathyroidism and steatorrhea: a new aid in management. J Pediatr 1974, 85:522-525.
105. Seeman E., Wahner H.W., Offord K.P., Kumar R., Johnson W.J., Riggs B.L. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 1982, 69:1302-1309.
106. Abugassa S., Nordenstrom J., Eriksson S., Sjoden G. Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 1993, 76:1617-1621.
107. Fujiyama K., Kiriyama T., Ito M., Nakata K., Yamashita S., Yokoyama N., et al. Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab 1995, 80:2135-2138.
108. Rubin M.R., Dempster D.W., Zhou H., Shane E., Nickolas T., Sliney J., et al. Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 2008, 23:2018-2024.
109. Langdahl B.L., Mortensen L., Vesterby A., Eriksen E.F., Charles P. Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 1996, 18:103-108.
110. Rubin M.R., Dempster D.W., Kohler T., Stauber M., Zhou H., Shane E., et al. Three dimensional cancellous bone structure in hypoparathyroidism. Bone 2010, 46:190-195.
111. Price P.A., Parthemore J.G., Deftos L.J. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980, 66:878-883.
112. Duda R.J., O'Brien J.F., Katzmann J.A., Peterson J.M., Mann K.G., Riggs B.L. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 1988, 66:951-957.
113. Kruse K., Kracht U., Wohlfart K., Kruse U. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment. Eur J Pediatr 1989, 148:535-539.
114. Ebeling P.R., Peterson J.M., Riggs B.L. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases. J Bone Miner Res 1992, 7:1243-1250.
115. Minisola S., Dionisi S., Pacitti M.T., Paglia F., Carnevale V., Scillitani A., et al. Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 2002, 13:171-175.
116. Raue F., Pichl J., Dorr H.G., Schnabel D., Heidemann P., Hammersen G., et al. Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia-a German survey. Clin Endocrinol (Oxf) 2011, 75:760-765.
117. Hossain M. Vitamin-D intoxication during treatment of hypoparathyroidism. Lancet 1970, 1:1149-1151.
118. Peacock M., Robertson W.G., Nordin B.E. Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1969, 1:384-386.
119. Winer K.K., Ko C.W., Reynolds J.C., Dowdy K., Keil M., Peterson D., et al. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 2003, 88:4214-4220.
120. Lienhardt A., Bai M., Lagarde J.P., Rigaud M., Zhang Z., Jiang Y., et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001, 86:5313-5323.
121. Boyce A.M., Shawker T.H., Hill S.C., Choyke P.L., Hill M.C., James R., et al. Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism. J Clin Endocrinol Metab 2013, 98:989-994.
122. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
123. Schussheim D.H., Jacobs T.P., Silverberg S.J. Hypocalcemia associated with alendronate. Ann Intern Med 1999, 130:329.
124. Kashyap A.S., Kashyap S. Hypoparathyroidism unmasked by alendronate. Postgrad Med J 2000, 76:417-418.
125. Tanimoto K., Okubo Y., Harada C., Saito H., Sata A., Nishikawa A., et al. Latent hypoparathyroidism in an osteoporotic patient with multiple endocrinopathies and secondary hemochromatosis due to multiple blood transfusions, unmasked by alendronate and glucocorticoid at adrenal crisis. Intern Med 2008, 47:515-520.
126. Franceschetti P., Bondanelli M., Caruso G., Ambrosio M.R., Lorusso V., Zatelli M.C., et al. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy. Bone 2013, 56:426-431.
127. Even L., Bader T., Hochberg Z. Nocturnal calcium, phosphorus and parathyroid hormone in the diagnosis of concealed and subclinical hypoparathyroidism. Eur J Endocrinol 2007, 156:113-116.
128. Cusano N.E., Maalouf N.M., Wang P.Y., Zhang C., Cremers S.C., Haney E.M., et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 2013, 98:2734-2741.